✦ LIBER ✦

SB-656104-A: A Novel 5-HT7 Receptor Antagonist with Improved in vivo Properties.

✍ Scribed by Ian T. Forbes; et al. et al.

Publisher: John Wiley and Sons
Year: 2003
Weight: 96 KB
Volume: 34
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200309124

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

For Abstract see ChemInform Abstract in Full Text.

📜 SIMILAR VOLUMES

In vivo pharmacology of irindalone, a 5-

In vivo pharmacology of irindalone, a 5-HT2 receptor antagonist with predominant peripheral effects

✍ Jørn Arnt; Klaus P. Bøgesø; Vita Boeck; Anne V. Christensen; Nils Dragsted; John 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

Improved prevention of moderately emetog

Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist : Results of a Phase III, single-dose trial versus dolasetron

✍ Peter Eisenberg; Jazmin Figueroa-Vadillo; Rosalio Zamora; Veena Charu; Julio Haj 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

## Background: Palonosetron, a highly selective and potent 5-ht(3) receptor antagonist with a strong binding affinity and a long plasma elimination half-life (approximately 40 hours), has shown efficacy in phase ii trials in preventing chemotherapy-induced nausea and vomiting (cinv) resulting from

Synthesis and AMPA Receptor Antagonistic

Synthesis and AMPA Receptor Antagonistic Activity of a Novel 7-Imidazolyl-6-trifluoromethyl Quinoxalinecarboxylic Acid with a Substituted Phenyl Group and Improved Its Good Physicochemical Properties by Introduced CF3 Group.

✍ Yasuo Takano; Futoshi Shiga; Jun Asano; Wataru Hori; Tsuyosi Anraku; Takashi Uno 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 24 KB 👁 2 views